CLS Q2: A quarter in line with our expectations - Redeye - Börskollen
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Aktieanalys

CLS Q2: A quarter in line with our expectations - Redeye

{newsItem.title}

Redeye provides an update following CLS’ Q2 report that fairly aligned with our expectations and did not include any significant surprises. Based on the report, we only make some minor estimate changes; however, our fair value range remains untouched.

Länk till analysen i sin helhet: https://www.redeye.se/research/1034482/cls-q2-a-quarter-in-line-with-our-expectations?utm_source=finwire&utm_medium=RSS

Nyheter om Clinical Laserthermia

Läses av andra just nu

Om aktien Clinical Laserthermia

Senaste nytt